组织学炎症可以预测未来的临床复发在性结肠炎患者内镜缓解期患者
Lauren A George1, Harris T Feldman2, Madeline Alizadeh1,3
1Division of Gastroenterology and Hepatology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
性结肠炎患者内镜改善仍有临床复发风险. 根据罗巴特的血清病理学指数 (RHI) 评估的组织学活性预测了复发,强调了其在性结肠炎 (UC) 管理中的重要性.
科学领域:
- 胃肠病学 胃肠病学
- 炎症性肠道疾病研究研究
- 临床结果 临床结果
背景情况:
- 内镜改善 (梅奥内镜评分[MES]0或1) 是性结肠炎 (UC) 的一个关键治疗目标.
- 评估UC患者内镜改善的临床复发风险对于优化治疗策略至关重要.
- 组织学活性在预测UC患者内镜改善的临床复发中的作用需要进一步调查.
研究的目的:
- 评估UC患者的临床复发风险,UC患者的MES为0或1.
- 为了确定组织学活性,使用罗巴茨组织病理学指数 (RHI),预测该患者队列中的临床复发.
- 为了比较不同结合内镜和组织学分数的患者之间的复发率.
主要方法:
- 追溯分析445名UC患者的MES0或1,没有先前的切除术,至少1年的随访.
- 收集人口统计,临床特征和临床复发数据.
- 由胃肠道病理学家使用Robarts Histopathologic Index (RHI) 的组织学评估.
主要成果:
- 95%的MES 0患者实现了组织学缓解 (RHI ≤ 3),而MES 1患者只有35%.
- 26%的患者经历了临床复发.
- 患有MES 1或RHI > 3的患者的复发率显著更高 (P < .01).
- 在调整年龄和性别后,组织学活性 (RHI > 3) 独立预测临床复发 (P = .008).
结论:
- 实现内镜改善的UC患者仍然存在临床复发的高风险.
- 通过RHI测量的组织学活性是UC临床复发的重要预测因素.
- 将组织学评估整合到常规UC管理中可能会改善临床结果的预测.
更多相关视频
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Ulcerative Colitis in IBD
